๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for High-Risk Localized Prostate Cancer

ABlative Radiotherapy (for) Unfavorable Prostate Tumors NCT04831983n/a1 site๐Ÿ“ Monza University of Milano Bicocca PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer NCT07426055Phase 2, Phase 31 site๐Ÿ“ Zamoล›ฤ‡ Affidea Nu-med Center of Oncological DIagnostics and Therapy ยท Tests: Stereotactic Body Radiotherapy (SBRT) Monotherapy, External Beam Radiotherapy (EBRT) Backbone, High-Dose-Rate Brachytheโ€ฆ Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogramโ‰ฅ7% NCT07115992NA1 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: RARPยฑSRT, RARP+ePLND High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma NCT04945642NA1 site๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: High-Dose Rate Brachytherapy, Stereotactic Body Radiation Therapy Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer NCT06990542Phase 21 site๐Ÿ“ La Jolla University of California, San Diego ยท Tests: Image-guided tumor-focused radiation therapy Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT NCT07455903Phase 21 site๐Ÿ“ Miami Baptist Health South Florida ยท Tests: Leuprolide, Degarelix, Relugolix, Triptorelin, Bicalutamide Focal Therapy for Localized Prostate Cancer NCT06270043n/a1 site๐Ÿ“ La Jolla University of California, San Diego ยท Tests: Focal Therapy Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer NCT06613100Phase 19 sites๐Ÿ“ San Francisco๐Ÿ“ St Louis๐Ÿ“ Columbus Amgen ยท Tests: Xaluritamig, GnRH Antagonist Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H) NCT06461793Phase 21 site๐Ÿ“ Seoul Samsung Medical Center ยท Tests: Dose increase after injection of biodegradable material A safety study of high-risk prostate cancer patients Circulating Tumor DNA in High Risk Localized Prostate Cancer NCT07222436n/a1 site๐Ÿ“ Pittsburgh University of Pittsburgh Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation NCT05806515Phase 2133 sites๐Ÿ“ Anchorage๐Ÿ“ Anchorage๐Ÿ“ Anchorage SWOG Cancer Research Network ยท Tests: Biospecimen Collection, Carboplatin, Chest Radiography, Computed Tomography, Magnetic Resonance Imaging Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer. NCT07645872n/a5 sites๐Ÿ“ Aix-en-Provence๐Ÿ“ Besanรงon๐Ÿ“ Colmar EDAP TMS S.A. PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT NCT07550517Phase 21 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: EBRT + 6 mo ADT + 177Lu-PSMA-617, EBRT + 24 mo ADT Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy NCT06798558Phase 23 sites๐Ÿ“ Washington D.C.๐Ÿ“ Washington D.C.๐Ÿ“ Hackensack Hackensack Meridian Health ยท Tests: Lu-17-PSMA-617 ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0 NCT07407608n/a1 site๐Ÿ“ Monza University of Milano Bicocca ยท Tests: SBRT, SDRT Two-fraction HDR Monotherapy for Localized Prostate Cancer NCT05665738NA1 site๐Ÿ“ San Francisco University of California, San Francisco ยท Tests: High Dose Rate Monotherapy High Intensity Focused Ultrasound in Prostate Cancer NCT06402357Phase 21 site๐Ÿ“ Gainesville University of Florida ยท Tests: Focal One high intensity focused ultrasound device Adjuvant Chemotherapy for High Malignant Prostate Cancer NCT06864533n/a3 sites๐Ÿ“ Beijing๐Ÿ“ Shenzhen๐Ÿ“ Baoding Peking University First Hospital ยท Tests: Docetaxel Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer NCT06178354NA1 site๐Ÿ“ Sacramento University of California, Davis ยท Tests: Cryosurgery, High-Intensity Focused Ultrasound Ablation, Survey Administration Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal) NCT06491056n/a1 site๐Ÿ“ Singapore Singapore General Hospital ยท Tests: Focal Therapy for Prostate Cancer Prospective Prostate Cancer Infrastructure NCT07560748n/a1 site๐Ÿ“ Nijmegen Radboud University Medical Center Registry for Prostate Cancer Focal Therapy NCT07792590n/a1 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: Focal Therapy for Prostate Cancer Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer NCT06220435NA2 sites๐Ÿ“ Lund๐Ÿ“ Umeรฅ Region Skane ยท Tests: Ultra-hypofractionated radiotherapy regimen. A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation NCT06952803Phase 3346 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ La Jolla AstraZeneca ยท Tests: Saruparib, Placebo, Abiraterone + Prednisolone/Prednisone, Androgen Deprivation Therapy (ADT) Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC NCT07172685NA1 site๐Ÿ“ Jinan Qilu Hospital of Shandong University ยท Tests: Darolutamide , Docetaxel , ADT and Transrectal HIFU Focal Therapy Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy NCT07792993n/a1 site๐Ÿ“ Rome Regina Elena Cancer Institute Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer NCT06200974n/a1 site๐Ÿ“ Kelowna British Columbia Cancer Agency ยท Tests: High dose rate prostate brachytherapy ยนโธF-PSMA-1007 PET-CT-Directed Focal Therapy for MRI-Invisible Prostate Cancer NCT07788625NA1 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: Focal Therapy for Prostate Cancer Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer NCT04549688NA1 site๐Ÿ“ Tรธnsberg The Hospital of Vestfold ยท Tests: high-intensity focused ultrasound, HIFU Clinical Study of HIFU for Localized Prostate Cancer NCT06362577n/a1 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: EQ-5D-5L IPSS IIEF-5 EPIC-26 ECOG
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy